8-K
Current Report
Protagenic Therapeutics, Inc.new Filed Acc 0001437749-17-013265
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading atrn20170726_8k.htm…